114 related articles for article (PubMed ID: 19182212)
1. Seroprevalence of HIV/HBV coinfection in Malian blood donors.
Tounkara A; Sarro YS; Kristensen S; Dao S; Diallo H; Diarra B; Noumsi TG; Guindo O
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):47-51. PubMed ID: 19182212
[TBL] [Abstract][Full Text] [Related]
2. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors.
Diarra A; Kouriba B; Baby M; Murphy E; Lefrere JJ
Transfus Clin Biol; 2009; 16(5-6):444-7. PubMed ID: 19896404
[TBL] [Abstract][Full Text] [Related]
3. [Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti].
Dray X; Dray-Spira R; Bronstein JA; Mattera D
Med Trop (Mars); 2005; 65(1):39-42. PubMed ID: 15903075
[TBL] [Abstract][Full Text] [Related]
4. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
Cunha L; Plouzeau C; Ingrand P; Gudo JP; Ingrand I; Mondlane J; Beauchant M; Agius G
J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus among blood donors, Phitsanulok Regional Blood Center, Thailand.
Luksamijarulkul P; Thammata N; Tiloklurs M
Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):272-9. PubMed ID: 12236425
[TBL] [Abstract][Full Text] [Related]
6. [Seroprevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among blood donors in Segou, Mali].
Koné MC; Sidibé ET; Mallé KK; Beye SA; Lurton G; Dao S; Diarra MT; Dao S
Med Sante Trop; 2012; 22(1):97-8. PubMed ID: 22868738
[TBL] [Abstract][Full Text] [Related]
7. Relative safety of first-time volunteer and replacement donors in West Africa.
Allain JP; Sarkodie F; Asenso-Mensah K; Owusu-Ofori S
Transfusion; 2010 Feb; 50(2):340-3. PubMed ID: 19843284
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
El-Hazmi MM
Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study.
Pahuja S; Sharma M; Baitha B; Jain M
Jpn J Infect Dis; 2007 Nov; 60(6):389-91. PubMed ID: 18032841
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
11. [Seroprevalence of HBV, HCV, and HIV among blood donors in Irapuato, Mexico].
Carreto-Vélez MA; Carrada-Bravo T; Martínez-Magdaleno A
Salud Publica Mex; 2003; 45 Supp 5():S690-3. PubMed ID: 14974281
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana.
Arora D; Arora B; Khetarpal A
Indian J Pathol Microbiol; 2010; 53(2):308-9. PubMed ID: 20551540
[TBL] [Abstract][Full Text] [Related]
13. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
14. [Seroprevalence of HBV and HCV in blood donors at the Blood Transfusion Center of Mohammed V Military Teaching Hospital in Rabat Morocco].
Zohoun A; Hadef R; Zahid H; Benkirane M
Med Trop (Mars); 2011 Oct; 71(5):513-4. PubMed ID: 22235634
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence and incidence of HIV and hepatitis B among blood donors and estimated residual risk of transmission of HIV and HBV virus by blood transfusion. A study at the Provincial General Referee Hospital Bukavu, Democratic Republic of the Congo].
Namululi BA; Guerrieri C; Dramaix MW
Rev Epidemiol Sante Publique; 2013 Apr; 61(2):139-44. PubMed ID: 23498094
[TBL] [Abstract][Full Text] [Related]
16. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
17. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
[TBL] [Abstract][Full Text] [Related]
19. [Seroprevalence of viral hepatitis B in the city of Mahajanga, Madagascar in 1999].
Migliani R; Rakoto Andrianarivelo M; Rousset D; Rabarijaona L; Randrianarisoa P; Roux JF
Med Trop (Mars); 2000; 60(2):146-50. PubMed ID: 11100440
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE
East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
